[
    [
        {
            "time": "",
            "original_text": "智飞生物持股5%以上股东累计减持2064万股",
            "features": {
                "keywords": [
                    "智飞生物",
                    "持股",
                    "减持",
                    "股东"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物持股5%以上股东累计减持2064万股",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物:业绩大幅增加,新型疫苗“暴力美学”逻辑逐季兑现",
            "features": {
                "keywords": [
                    "智飞生物",
                    "业绩",
                    "增加",
                    "新型疫苗",
                    "暴力美学",
                    "逻辑",
                    "逐季兑现"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物:业绩大幅增加,新型疫苗“暴力美学”逻辑逐季兑现",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[增持评级]医药生物行业周报：医药板块维持较高景气度 布局优质龙头",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业周报",
                    "医药板块",
                    "景气度",
                    "优质龙头",
                    "增持评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业周报：医药板块维持较高景气度 布局优质龙头",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "东吴医药行业周观点：HPV 9价疫苗8天审核通过、抗癌药物大幅减税 从研发审评到支付优惠 政策全面鼓励药品创新",
            "features": {
                "keywords": [
                    "东吴医药",
                    "HPV",
                    "9价疫苗",
                    "审核通过",
                    "抗癌药物",
                    "减税",
                    "政策",
                    "药品创新"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴医药行业周观点：HPV 9价疫苗8天审核通过、抗癌药物大幅减税 从研发审评到支付优惠 政策全面鼓励药品创新",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[看好评级]医药生物行业周报：业绩整体表现良好 重点关注突出细分行业",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业周报",
                    "业绩",
                    "整体表现",
                    "良好",
                    "细分行业",
                    "看好评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业周报：业绩整体表现良好 重点关注突出细分行业",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[优于大势评级]医药生物行业深度报告：行业持续改善 18Q1迎来小爆发",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业深度报告",
                    "持续改善",
                    "18Q1",
                    "小爆发",
                    "优于大势评级"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[优于大势评级]医药生物行业深度报告：行业持续改善 18Q1迎来小爆发",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]